logo

TECH

Bio-Techne·NASDAQ
--
--(--)
--
--(--)
9.89 / 10
Outperform

Fundamental breakdown reveals excellent profile (9.9/10). Supportive elements: Asset-MV and Net income-Revenue, balanced by issues in Revenue-MV and Current assets turnover ratio. This suggests excellent positioning.

Fundamental(9.89)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-1.09
Score0/3
Weight-132.32%
1M Return-2.92%
Net profit attributable to parent company shareholders / Net profit (%)
Value99.95
Score2/3
Weight-61.15%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value5.23
Score3/3
Weight80.08%
1M Return1.68%
Net cash flow from operating activities / Operating revenue (%)
Value23.58
Score3/3
Weight72.97%
1M Return1.58%
Net income-Revenue
Value0.15
Score3/3
Weight311.39%
1M Return5.60%
Net profit margin (%)
Value6.02
Score3/3
Weight69.95%
1M Return1.57%
Current assets turnover ratio
Value1.99
Score1/3
Weight-66.55%
1M Return-1.72%
EBIT / Total operating revenue (%)
Value8.45
Score0/3
Weight-225.90%
1M Return-7.44%
Asset-MV
Value-1.25
Score2/3
Weight-18.41%
1M Return-0.42%
Net profit / Total operating revenue (%)
Value6.02
Score3/3
Weight69.95%
1M Return1.57%
Is TECH undervalued or overvalued?
  • TECH scores 9.89/10 on fundamentals and holds a Discounted valuation at present. Backed by its 3.88% ROE, 6.67% net margin, 128.89 P/E ratio, 5.20 P/B ratio, and -47.00% earnings growth, these metrics solidify its Outperform investment rating.